Table 4.
Expected test savings (in terms of mastermix) for each disease syndrome/sample type.
| Sample | Annual total | Number of tests carried out (pre-multiplex) | Number of test carried out (post-multiplex) | Total difference (%) |
|---|---|---|---|---|
| Eye | ∼2,000 | 8,000 | 2,000 | 75 |
| Stool (non-outbreak) | ∼1,600 | 6,400 | 1,600 | 75 |
| CSF | ∼1,600 | 11,200 | 6,400 | 43 |
| Vesicle fluid | ∼2,000 | 4,000 | 2,000 | 50 |
| Genital | ∼2,000 | 2,000 | 2,000 | 0 |
| Blood (TX) | ∼3,000 | 9,000 | 3,000 | 66 |
| Total | ∼12,200 | 40,600 | 17,000 | 58.2 |